Key result
A delay to surgery of >60 days was not associated with worse biochemical recurrence-free survival in men with localized prostate cancer (5-year survival 78-85% across groups, P=0.11).
Why the study?
Does delaying radical prostatectomy >60 days worsen biochemical recurrence-free survival in men with localized prostate cancer?
Cohort (n=1,568)
No
Does delaying radical prostatectomy >60 days worsen biochemical recurrence-free survival in men with localized prostate cancer?
p-value: p=0.11
Delaying radical prostatectomy for more than 60 days does not adversely affect biochemical recurrence-free survival in men with localized prostate cancer.
No takes yet. Share an insight, caveat, or question.
May support delayed surgery in localized prostate cancer; hypothesis-generating from Level 5 data and needs prospective validation.
Korets et al. (2011) conducted a cohort in Localized prostate cancer (n=1,568). Surgical delay >60 days vs. Surgical delay ≤60 days was evaluated on 5-year survival rate (p=0.11). A delay to surgery of >60 days was not associated with worse biochemical recurrence-free survival in men with localized prostate cancer (5-year survival 78-85% across groups, P=0.11).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: